UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                 SCHEDULE 13D/A


                    UNDER THE SECURITIES EXCHANGE ACT OF 1934
                               (AMENDMENT NO. 3)*


                               Blue Holdings, Inc.
--------------------------------------------------------------------------------
                                (Name of Issuer)

                     Common Stock, par value $.001 per share
--------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                   095602 10 8
--------------------------------------------------------------------------------
                                 (CUSIP Number)

                                Alexandre Caugant
                             c/o Blue Holdings, Inc.
                              5804 E. Slauson Ave.
                           Commerce, California 90040
                                 (323) 725-5555
--------------------------------------------------------------------------------
 (Name, Address and Telephone Number of Person Authorized to Receive Notices and
                                 Communications)

                                  May 22, 2006
--------------------------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

     If  the  filing  person has previously filed a statement on Schedule 13G to
report  the acquisition which is the subject of this Schedule 13D, and is filing
this  schedule  because  of  Rule  13d-1(e),  13d-1(f)  or  13d-1(g),  check the
following  box  [ ].

     NOTE:  Schedules  filed in paper format shall include a signed original and
five  copies  of the schedule, including all exhibits.  See Rule 13d-7 for other
parties  to  whom  copies  are  to  be  sent.

                                  (Page 1 of 5)

-------------------
*The  remainder  of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent  amendment  containing  information  which  would  alter
disclosures  provided  in  a  prior  cover  page.

The information required on the remainder of this cover page shall not be deemed
to  be  "filed"  for the purpose of Section 18 of the Securities Exchange Act of
1934  or  otherwise  subject  to  the liabilities of that section of the Act but
shall  be  subject  to all other provisions of the Act (however, see the Notes).





CUSIP NO.  095602 108                                                            PAGE  2  OF  4  PAGES
           ----------                                                                -----   ----

            
------------------------------------------------------------------------------------------------------
1              NAME OF REPORTING PERSON
               SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

               ALEXANDRE CAUGANT
------------------------------------------------------------------------------------------------------
2              CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                               (a) [ ]
                                                                                               (b) [ ]
------------------------------------------------------------------------------------------------------
3              SEC USE ONLY

------------------------------------------------------------------------------------------------------
4              SOURCE OF FUNDS*

               OO
------------------------------------------------------------------------------------------------------
5              CHECK BOX OF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
               [ ]
------------------------------------------------------------------------------------------------------
6              CITIZENSHIP OR PLACE OF ORGANIZATION

               FRANCE
------------------------------------------------------------------------------------------------------
  NUMBER OF    7       SOLE VOTING POWER
                       1,064,741
   SHARES      ---------------------------------------------------------------------------------------
               8       SHARED VOTING POWER
BENEFICIALLY
               ---------------------------------------------------------------------------------------
OWNED BY EACH  9       SOLE DISPOSITIVE POWER
                       1,064,741
  REPORTING    ---------------------------------------------------------------------------------------
               10      SHARED DISPOSITIVE POWER
PERSON WITH
------------------------------------------------------------------------------------------------------
11             AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

               1,064,741
------------------------------------------------------------------------------------------------------
12             CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*              [ ]

------------------------------------------------------------------------------------------------------
13             PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

               4.1% (1)
------------------------------------------------------------------------------------------------------
14             TYPE OF REPORTING PERSON*

               IN
------------------------------------------------------------------------------------------------------


(1)  Based on  a  total of 26,057,200 shares of the Issuer's common stock issued
     and  outstanding  as  of  July  31,  2006.



     This Schedule 13D/A ("Schedule 13D/A") amends the following sections of the
Schedule  13D  filed with the Securities and Exchange Commission on May 3, 2005,
as  amended  by  the Schedule 13D/A No. 1 filed with the Securities and Exchange
Commission  on  October  28,  2005  and  the Schedule 13D/A No. 2 filed with the
Securities  and  Exchange  Commission  on  November  18,  2005 ("Schedule 13D").

ITEM 3.  SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

     Item  3  of  Schedule  13D  is  supplemented and amended by the information
below.

     In reliance upon and pursuant to the Company's Post-Effective Amendment No.
3  to  the  Company's  Registration Statement on Form SB-2 on Form S-3 (File No.
333-128288)  declared  effective  on  May  19,  2006, covering the resale of the
shares  of Common Stock held by the Reporting Person, in May 2006, the Reporting
Person  sold  an  aggregate  of  300,000  shares  of  Common  Stock.

ITEM 5.  INTEREST IN SECURITIES OF THE ISSUER.

     Item  5  of  Schedule  13D  is  supplemented and amended by the information
below.

     Reference is made to the disclosure set forth under Item 3 of this Schedule
13D/A,  which  disclosure  is  incorporated  herein  by  reference.

     As  of  July  31,  2006,  the Reporting Person beneficially owned 1,064,741
shares  of  Common Stock (the "Shares"). Since 26,057,200 shares of Common Stock
were  outstanding  as of July 31, 2006, the Shares constitute approximately 4.1%
of  the  shares  of  Common  Stock  issued  and  outstanding.

     The  Reporting Person has the sole power to vote or direct the vote of, and
to  dispose  of  or  direct  the  disposition  of,  the  Shares.

     Transactions  by  the Reporting Person in Common Stock effected in the past
60  days  are  described  in  Item  3  above.

     On  May 22, 2006, the Reporting Person ceased to be the beneficial owner of
more  than  five  percent  of the shares of Common Stock issued and outstanding.



                                    SIGNATURE
     After  reasonable  inquiry and to the best of its knowledge and belief, the
undersigned  certifies  that  the  information set forth in this Schedule 13D is
true,  complete  and  correct.

Dated: August 7, 2006              /s/ Alexandre Caugant
                                   -------------------------
                                        Alexandre Caugant


                                       4